Transplantation of allogeneic peripheral blood progenitor cells - The EBMT experience

Bone Marrow Transplantation

Volumn 17, Issue SUPPL. 2, 1996, Pages

  Schmitz, N ^a   Bacigalupo, A ^b   Labopin, M ^c   Majolino, I ^d   Laporte, J P ^c   Brinch, L ^e   Cook, G ^f   Lambertenghi Deliliers, G ^g   Lange, A ^h   Rozman, C ⁱ   Garcia Conde, J ^j   Finke A, J ^k   Domingo Albos, ^l   Gratwohl, A ^m  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF GENOA   (Italy)

^c HÔPITAL SAINT ANTOINE   (France)

^d VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f GLASGOW ROYAL INFIRMARY   (United Kingdom)

^g UNIVERSITY OF MILAN   (Italy)

^h INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

ⁱ HOSPITAL CLÍNIC   (Spain)

^j HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^k UNIVERSITY OF FREIBURG   (Germany)

^l HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^m UNIVERSITY HOSPITAL BASEL   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; PREDNISOLONE; THIOTEPA;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; CHRONIC MYELOID LEUKEMIA; CONFERENCE PAPER; CYTOMEGALOVIRUS; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HLA MATCHING; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SCHOOL CHILD; STEM CELL TRANSPLANTATION; SURVIVAL; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; BLOOD DONORS; BUSULFAN; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; ERYTHROPOIETIN; FEMALE; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; LEUKEMIA; LYMPHOMA; LYMPHOPROLIFERATIVE DISORDERS; MALE; METHOTREXATE; MIDDLE AGED; PREDNISOLONE; WHOLE-BODY IRRADIATION;

EID: 15844370317     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. KÖRBLING M, PRZEPIORKA D, HUH YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995, 85: 1659-1665.
2. BENSINGER WI, WEAVER CH, APPELBAUM FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995, 85: 1655-1658.
3. SCHMITZ N, DREGER P, SUTTORP M et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995, 85: 1666-1672.
4. KORBLING M, HUH YO, DURETT A et al Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 1995, 86: 2842-2848.
5. DREGER P, HAFERLACH T, ECKSTEIN V et al. G-CSF-mobilised peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Haematol 1994, 87: 609-613.
6. ATKINSON K, FARRELL C, CRAPMAN G, DOWNS K, PENNY R, BIGGS J. Female marrow donors increase the risk of acute graft-versus-host disease: effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum. Br J Haematol 1986, 63:231-239.
7. GRATAMA JW, STIJNEN T, WEILAND HT et al. Herpes-virus immunity and acute graft-versus-host disease. Lancet 1987, i: 471-474.
8. GALE RP, BORTIN MM, VAN BEKKUM DW et al. Risk factors for acute graft-versus-host disease. Br J Haematol 1987, 67: 397-406.
9. SULLIVAN KM, KOPECKY KJ, JOCOM J et al. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med 1990, 323: 705-712.
10. WEISDORF D, HAKKE R, BLAZAR B et al. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation 1991, 51: 1197-1203.
11. BEELEN DW, HARALAMBIE E, BRANDT H et al. Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation. Blood 1992, 80: 2668-2676.
12. NASH RA, PEPE MS, STORB R et al. Acute graft-versus-host disease: Analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 1992, 80: 1838-1845.
13. CHAO NJ, SCHMIDT GM, NILAND JC et al. Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease. W Engl J Med 1993, 329: 1225-1230.
14. VON BUELTZINGSLOEWEN A, BELANGER R, PERREAULT C et al. Acute graft-versus-host disease prophylaxis with methotrexate and cyclosporine after bulsulfan and cyclophsophamide in patients with hematologic malignancies. Blood 1993, 81: 849-855.
15. STORE R, DEEG HJ, PEPE M et al. Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: Long-term follow-up of a controlled trial. Blood 1989, 73: 1729-1734.
16. ATKINSON K, HOROWITZ MM, GALE RP et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 1990, 75: 2459-2464.
17. SULLIVAN KM, AGURA E, ANASETTI C et al. Chronic graft-versus-host disease and other late complictaions of bone marrow transplantation. Sem Hematol 1991, 28: 250-259.
18. SHERIDAN WP, BEGLEY CG, JUTTNER CA et al. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992, 339: 640-644.
19. SCHMITZ N, LINCH DC, DREGER P et al. Filgrastim-mobilised peripheral blood progenitor cell transplantation in comparison with autologous bone marrow transplantation: results of a randomised phase III trial in lymphoma patients. Lancet (in press)